The week ended with more noise than signal — geopolitical headlines dominating feeds while the market quietly digested a mixed bag of earnings and economic data. Seven dead in a Jordan church attack. Trump floating military action against Iran and "taking care of Cuba" on the way back. Iran threatening Gulf undersea cables. A Saudi missile plant expansion. A building collapse in Nairobi. The Bank of Canada polling for a rate hike to 2.50% on October 28. CrowdStrike's CEO making waves with an "alarming prediction." Bond market bargain hunters emerging. College campuses going quiet.

Underneath it all, Daloop's system closed 8 trades between October 16 and October 23. Three winners. Five losers. A 38% win rate with an average return of 0.2% and an average hold of 77 days. The portfolio currently holds 185 open positions across 316 qualified names from a 421-ticker universe.

The Week in Trades

PepsiCo (PEP) closed Friday at a -9.6% loss after 149 days. The consumer staples giant has been navigating volume pressure and pricing fatigue — a reminder that even defensive names aren't immune when the consumer pulls back. This PEP stock analysis October 2026 shows how a long hold in a "safe" sector can still produce a meaningful drawdown when the thesis doesn't play out.

UDR (UDR Inc.) exited the same day, down -4.2% over 52 days. The apartment REIT has faced headwinds from new supply absorption and rate-sensitive financing costs. The UDR stock analysis October 2026 reflects a sector still working through the overbuilding hangover in key Sun Belt markets.

Exelon (EXC) closed at a -3.9% loss after 127 days. The utility's nuclear-heavy fleet should be a tailwind in a power-hungry AI era, but regulatory overhang and Illinois rate case uncertainty have kept a lid on the stock. The EXC stock analysis October 2026 captures that tension between structural demand and near-term policy friction.

General Dynamics (GD) took a -9.5% hit over 40 days — a sharp, fast loss in a name that's supposed to be a defense stalwart. The Saudi missile plant expansion headlines underscore the geopolitical tailwind, but program timing and margin mix created a gap between narrative and numbers.

Duke Energy (DUK) rounded out the losses at -4.6% over 123 days. Another utility, another regulatory wait. The Carolinas rate case timeline has been the driver here — slow, predictable, and frustrating for capital that wants to compound.

On the win side, IBM delivered +14.3% over 69 days. The software-and-consulting pivot continues to show up in the numbers, even if the market still debates the multiple. Pacific Biosciences (PACB) ripped +18.5% in just 3 days — a biotech sprint that reminds you how fast sentiment can flip on a catalyst. First Trust Dow Jones Internet ETF (FDN) scratched out +0.6% over 53 days, a quiet win that mostly just didn't lose money while tech chopped.

Five losses. Three wins. The math is the math. The system's risk overlay — the proprietary mechanism that sizes positions and manages exposure — is designed precisely for weeks like this: keep the losers small, let the winners run, and stay in the game for the next cluster of outliers. A -9.6% loss on PEP stings, but it's the cost of holding a position that could have been a +30% winner. The overlay limits the damage. The portfolio remains net positive across the 185 open positions.

What to Watch

CrowdStrike (CRWD) — The cybersecurity leader's CEO issued an "alarming prediction" this week per CNBC, though the specifics weren't detailed in available headlines. The stock has been volatile since the July global outage; any forward guidance shift moves the needle. Watch for enterprise renewal commentary and whether the platform consolidation thesis holds through budget season.

Bank of Canada rate decision (October 28) — Not a ticker, but a macro catalyst. Reuters reports a poll showing a hike to 2.50% next week and another by end-March. This matters for Canadian banks (RY, TD, BMO, CM, BNS) and rate-sensitive sectors north of the border. If you hold cross-listed names or CAD exposure, the forward guidance language will matter more than the 25-bp move itself.

Defense sector (RTX, LMT, NOC, L3Harris) — The exclusive Reuters report on Saudi missile plant expansion potentially producing more powerful missiles adds to the multi-year rearmament cycle. GD just exited at a loss, but the sector thesis — NATO spending floors, Indo-Pacific buildup, Middle East modernization — remains intact. Watch Q3 order flow and 2025 guidance at upcoming earnings.

Bond market (TLT, IEF, HYG) — CNBC notes investors "starting to find opportunities in the battered bond market." With the 10-year yield having backed up significantly, duration risk is being reassessed. The Bank of Canada hike expectation and sticky U.S. inflation prints keep the Fed path uncertain. If you're allocating to fixed income via ETFs, the entry point conversation has shifted from "when" to "how much duration."

IBM — Fresh off a +14.3% win in the portfolio, the stock heads into its next earnings window with the software revenue mix improving and consulting stabilizing. The Red Hat integration is largely in the rearview; the question is whether GenAI consulting demand sustains the multiple expansion.

PACB — A +18.5% gain in 3 days is the definition of a biotech catalyst trade. The company's long-read sequencing platform has niche but growing adoption in clinical research. Watch for instrument placement numbers and consumable pull-through — that's where the recurring revenue story lives.


The dashboard has the full ledger — every entry, every exit, every hold time. If you want to see how the 38% win rate translates across a full cycle, it's all there. No narrative required.